Cardiovascular Manifestations in Systemic Lupus Erythematosus. Prospective Study of 100 Patients

Badui, Elias; Garcia-Rubi, David; Robles, Elsa; Jimenez, Javier; Juan, Lourdes; Deleze, Margarita; Diaz, Arluro; Mintz, Gregorio
July 1985
Angiology;Jul1985, Vol. 36 Issue 7, p431
Academic Journal
One hundred consecutive female patients with active systemic lupus erythematosus (SLE) were studied from the cardiovascular point of view by means of non invasive methods. Seventy percent of the cases presented some type of cardiovascular anomaly. Seventy four percent of the resting electrocardiograms were abnormal as well as 72% of the M mode echocardiograms and 55% of the cardiac X ray series. The most frequent observed complications were: pericarditis and or pericardial effusion (39%), arterial hypertension (22%), ischemic heart disease (16%), myocarditis (14%), congestive heart failure (10%), pulmonary hypertension (9%), valvular heart disease (9%), pleural effusion (7%) and cerebro vascular accident (3%). We analized each one of these complications and found of special interest the high incidence of ischemic heart disease which is more frequent than has been hitherto reported. Ischemic heart disease was observed in two types of patients: a) Those with long term steroid therapy. In these, the mechanism seems to be an atherosclerotic disease probably induced by the chronic use of steroids. The management of these cases do not differ from other types of coronary heart disease due to atherosclerosis, b) Those with frank episodes of vasculitis in whom the basic mechanism is an inflammatory process of the coronary arteries and its treatment is fundamentally that of the vasculitis. We consider necessary to study routinely all patients with SLE through non invasive cardiological methods.


Related Articles

  • Emergency Aortic Valve Replacement in Systemic Lupus Erythematosus Kumar, Sanjay; Sinha, Bharati; Ravikumar, Edwin // Heart, Lung & Circulation;Dec2006, Vol. 15 Issue 6, p397 

    The valvular heart disease in systemic lupus erythematosus (SLE) is associated with substantial morbidity and mortality. Current therapy includes symptomatic measures and valve replacement. Overall mortality of valve replacement has been reported to be as high as 25%. Most cases of...

  • Epidemiology of cardiovascular disease in systemic lupus erythematosus. Aranow, C.; Ginzler, E.M. // Lupus;2000, Vol. 9 Issue 3, p166 

    Awareness of the impact of cardiovascular disease on the late morbidity and mortality in patients with Systemic Lupus Erythematosus (SLE) is increasing. Clinical events secondary to accelerated atherosclerosis have been documented in lupus cohorts across the globe. We review the history and...

  • A CLINICAL STUDY OF A MULTIFACETED TREATMENT IN CORONARY INSUFFICIENCY. Eisfelder, Henry W. // Angiology;Mar1961, Vol. 12 Issue 3, p109 

    Sixty-eight subjects with coronary insufficiency, 23 postcoronary patients and 45 with developing arteriosclerotic heart disease, were placed on a program consisting of three elements: emergency medication (nitroglycerin), a long-acting protective agent (trolnitrate phosphate), and reassurance...

  • A case of a single coronary artery originating from left coronary sinus of Valsalva associated with serious coronary artery disease. Büyükkaya, Eyüp; Arslan, Şakir; Şenocak, Hüseyin // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Jun2007, Vol. 7 Issue 2, p244 

    The article presents the case of a 77-year-old woman diagnosed with a single coronary artery originating from left coronary sinus of Valsalva. This condition was associated with serious coronary artery disease. Electrocardiogram showed sinus rhythm, reduction in R wave height and abnormally tall...

  • Systemic lupus erythematosus and cardiac risk factors: medical record documentation and patient adherence. Bengtsson, C; Bengtsson, AA; Costenbader, KH; Jönsen, A; Rantapää-Dahlqvist, S; Sturfelt, G; Nived, O // Lupus;Oct2011, Vol. 20 Issue 10, p1057 

    This study explores patients’ knowledge of cardiac risk factors (CRFs), analyses how information and advice about CRFs are documented in clinical practice, and assesses patient adherence to received instructions to decrease CRFs. Systemic lupus erythematosus (SLE) patients...

  • MACROMOLECULES IN THE ARTERIAL WALL IN RELATION TO INJURY AND REPAIR--A SURVEY. Berenson, Gerald S.; Radhakrishnamurthy, Bhandaru; Srinivasan, Sathanur R.; Dalferes Jr., Edward R. // Angiology;Nov1974, Vol. 25 Issue 10, p649 

    C-V connective tissue plays an important role in many forms of heart and blood vessel diseases. A general background of macromolecules of connective tissue is presented, and examples of disease are shown which may be considered as metabolic forms of injury requiring repair by connective tissue....

  • Microembolic signals in systemic lupus erythematosus and other cerebral small vessel diseases. Baizabal-Carvallo, José; Samson, Yves // Journal of Neurology;Apr2010, Vol. 257 Issue 4, p503 

    Microembolic signals (MES) are detected by transcranial Doppler (TCD), and are mainly observed in cardiac and large-artery diseases; however they might also be observed in conditions affecting small vessels of the brain. We aimed to review the current medical literature related to MES assessed...

  • Novel cardiovascular risk prediction models in patients with systemic lupus erythematosus. Kawai, VK; Solus, JF; Oeser, A; Rho, YH; Raggi, P; Bian, A; Gebretsadik, T; Shintani, A; Stein, CM // Lupus;Dec2011, Vol. 20 Issue 14, p1526 

    Women with systemic lupus erythematosus (SLE) have increased risk for coronary heart disease (CHD) which is underestimated by the Framingham risk score (FRS). We hypothesized that new risk scores that include inflammation or vascular age in the risk calculation would better identify women with...

  • Premature coronary heart disease in SLE: can we prevent progression? Iaccarino, L; Bettio, S; Zen, M; Nalotto, L; Gatto, M; Ramonda, R; Punzi, L; Doria, A // Lupus;Oct2013, Vol. 22 Issue 12, p1232 

    Patients with systemic lupus erythematosus (SLE) have a higher prevalence of clinical and subclinical atherosclerosis compared with age- and sex-matched controls. Atherosclerosis progression is also accelerated in SLE, and coronary heart disease (CHD) is a major cause of morbidity and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics